RxDoctor Payments DataLook up a doctor →

Paul Watkins

Gastroenterology · Chapel Hill, NCNPI 1386705366

Payments from drug & device makers

$1,070,902in general payments, 2019–2025

Across 276 payments — averaging $3880.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$197K
  • Intercept Pharmaceuticals, Inc.$101K
  • Pfizer$83K
  • Mirum Pharmaceuticals, Inc.$55K
  • Janssen Research & Development, LLC$51K
  • Actelion Pharmaceuticals, Ltd$49K
  • plus $535K from 54 others
$1,250in research payments, 2019–2025

Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer12$197,014
Intercept Pharmaceuticals, Inc.8$100,947
Pfizer27$83,222
Mirum Pharmaceuticals, Inc.3$54,925
Janssen Research & Development, LLC16$50,675
Actelion Pharmaceuticals, Ltd5$48,850
Takeda Pharmaceuticals U.S.A., Inc.8$47,119
Merck5$43,473
AbbVie(2 entities)30$42,094
Sarepta Therapeutics, Inc.15$27,645
GW Research Limited2$24,400
F. Hoffmann-la Roche AG11$21,836
Biohaven Pharmaceuticals, Inc.3$19,963
Jazz Pharmaceuticals Inc.16$19,578
HRA Pharma7$19,247
UCB SA2$19,013
Biogen7$18,558
Spark Therapeutics, Inc.13$18,240
Astellas Pharma Global Development3$14,788
Sanofi3$12,402
Amgen4$10,681
Daiichi Sankyo Inc.6$10,613
Boehringer Ingelheim International GmbH2$10,433
Servier Bioinnovation2$10,400
Acorda Therapeutics, Inc7$9,801
Eli Lilly1$9,450
Gilead4$8,448
Bristol Myers Squibb4$8,320
PTC Therapeutics, Inc.4$8,125
Alnylam Pharmaceuticals Inc.3$7,395
Geron Corporation3$7,000
UCB Biosciences Inc.2$6,500
Ferring International Pharmascience Center US1$6,439
Xeris Pharmaceuticals, Inc.2$6,375
Novo Nordisk1$6,000
E.r. Squibb & Sons, L.L.C.1$5,688
Alkermes, Inc.2$4,800
Sanofi US Services Inc.2$3,944
Blueprint Medicines Corporation1$3,876
EMD Serono, Inc.2$3,750
Myovant Sciences GmbH1$3,589
Akebia Therapeutics Inc1$3,413
Novo Nordisk Health Care AG1$3,375
Sage Therapeutics, LLC2$3,348
Agios Pharmaceuticals, Inc.2$3,000
Novartis Pharma AG1$2,275
Biohaven Pharmaceutical Holding Company Ltd.1$2,275
Greenwich Biosciences, Inc.1$2,000
CSL Behring1$1,875
Mitsubishi Tanabe Pharma Development America, Inc.2$1,788
Acadia Pharmaceuticals Inc2$1,650
Grifols, S.A.2$1,625
Exelixis Inc.1$1,625
Seagen Inc.1$1,138
Novartis1$1,000
Genentech, Inc.1$1,000
Almirall LLC1$1,000
Biomarin Pharmaceutical Inc.1$1,000
Strongbridge US Inc.1$750
Boehringer Ingelheim1$655

How this compares

$1,070,902 in reported general payments places this provider in the 95th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina

Other gastroenterology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →